The stock's yield is more than six times the S&P 500 average.

Top stock market recommendations: Ambuja Cements, Asahi India Glass, and Pfizer - these stocks have been identified as the ...

Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...

Pfizer heads into Q2 earnings with expectations for growth in key products, COVID headwinds, and guidance updates that could ...

Pfizer (NYSE: PFE) shares gained 2.8% through 11:15 a.m. ET Thursday, and investors can thank the friendly bankers at RBC Capital Markets for that. This morning, RBC removed its sell rating from ...

Pfizer’s PFE stock has been trading below both its 50-day and 200-day simple moving averages (SMAs) since mid-June, indicating continued caution among investors regarding the co ...

Pfizer Q2 earnings: shares rise despite obesity drug cuts; tafamidis and Abrysvo sales surge. Click here to read my most ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNTech SE (BNTX) and Pfizer (PFE) with bullish sentiments. According to TipRanks.com, Gillis is a ...

Pfizer's non-COVID-19 portfolio demonstrates resilience, with Padcev, Vyndamax, and new launches driving operational growth ...

Pfizer stock currently trades at less than 9 times forward earnings while yielding more than 6%, making it one of the cheapest large-cap pharmaceutical stocks on the market. That immediately gets ...

Don't let their recent poor performances chase you away.